Overview:
Yellow fewer is caused by Aedes aegypti mosquitoes, as these mosquitoes are vectors in transmitting the disease. Yellow fewer can be prevented by taking vaccination. The same species of mosquitoes are responsible for transmitting dengue and Zika virus. These mosquitoes can be found in humid environments as well as tropical rainforests and semi-humid environments. Headache, nausea, fever, and vomiting are the common symptoms of yellow fever. It also affects various organs like the liver, heart and kidneys. According to the WHO, 50% of people suffering from yellow fewer can lose their lives as they develop severe symptoms.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4774
Impact of COVID-19:
The pandemic has impacted clinical trials, as many of them have been paused due to COVID-19. Researchers are facing huge challenges in carrying out clinical trials. Supplying raw materials for the manufacture of drugs owing to disruptions in transport systems is one of the major challenges faced by them.
COVID-19 has had a negative impact in countries like India, Brazil and Pakistan, as it impacted the preventive measures against vector-borne diseases. Due to COVID-19, a decrease in vaccination rate of measles and yellow fever was witnessed in 2020.
Moreover, increased support from several organizations for carrying out vaccination in large numbers is expected to propel growth of the global yellow fever treatment market over the forecast period. For instance, the GAVI Alliance, has invested more than US$ 500 million since 2001, for controlling the spread of yellow fever and they are aiming to protect lives by carrying out immunization of individuals. They focus mainly on the African countries as majority of deaths occur due to yellow fewer.
Drivers:
Rising research and development activities for the production of a new vaccines for yellow fever is anticipated to augment growth of the global yellow fever treatment market during the forecast period. For instance, Saint Louis University’s Center for Vaccine Development had initiated examining a vaccine for yellow fever in July 2021. Sanofi Pasteur funded this research and there is a need for developing a new vaccine as the vaccine currently used consists of egg protein which cannot be used for individuals allergic to egg.
Key Takeaways:
- The global yellow fever treatment market is anticipated to exhibit a CAGR of 3.7% over the forecast period, owing to rising research and development activities. For instance, the Eliminate Yellow fever Epidemics Strategy was initiated in 2017, it had around 50 partners and they supported almost 40 nations which were under the risk. This partnership was aiming to protect populations at the risk of yellow fever and also stop the spread of the virus. They are aiming to protect more than 1 billion people by 2026.
- North America is expected to witness significant growth in the global yellow fever treatment market during the forecast period, due to increasing incidences of yellow fever, increase in fundings by the government and growth of the healthcare industry.
Key Players:
Key players active in the global yellow fever treatment market are Institut Pasteur de Dakar, Tychan Pte. Ltd., Sanofi Pasteur SA, Bio-Manguinhos, Janssen, FSUE Chumakov, Pfizer Inc., Takeda Pharmaceutical Company Limited, Bayer AG, BIOCRYST PHARMACEUTICALS, INC., GlaxoSmithKline plc, Johnson & Johnson Services, Inc, and Johnson & Johnson Services, Inc.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/4774
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Yellow Fever Treatment Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Yellow Fever Treatment Industry Impact
Chapter 2 Global Yellow Fever Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Yellow Fever Treatment (Volume and Value) by Type
2.3 Global Yellow Fever Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Yellow Fever Treatment Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Yellow Fever Treatment Market Analysis
Chapter 6 East Asia Yellow Fever Treatment Market Analysis
Chapter 7 Europe Yellow Fever Treatment Market Analysis
Chapter 8 South Asia Yellow Fever Treatment Market Analysis
Chapter 9 Southeast Asia Yellow Fever Treatment Market Analysis
Chapter 10 Middle East Yellow Fever Treatment Market Analysis
Chapter 11 Africa Yellow Fever Treatment Market Analysis
Chapter 12 Oceania Yellow Fever Treatment Market Analysis
Chapter 13 South America Yellow Fever Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Yellow Fever Treatment Business
Chapter 15 Global Yellow Fever Treatment Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/4774
About US
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com